Twitter Beğeni Hilesi

Excited to host my former Penn Medicine colleague and friend Dr SoniaGuedan next week, looking forward to this! Join us live or on webex! Find the link below 👇

Grateful to Swiss National Science Foundation for supporting our research and excited to start this project with Andrea and Bruno !!!#andreaablasser Bruno Correia BRIDGE Programme (SNSF / Innosuisse)

Thanks to the Geneva Centre for Inflammation Research organizing committee for inviting me, looking forward to this!

Geneva Centre for Inflammation Research seminar on #Cancer #Immunotherapy! Friday 10 February at 14:00h CMU A. Franceschetti C02.2245 Speakers: Prof. Philippe Bousso, INSTITUT PASTEUR Prof. Denis Migliorini, & Dr. Federico Simonetta, UNIGE_en @Hopitaux_unige #CARTcells #glioma #CellularTherapies #GvHD

Thanks a lot GCIR, Dr Elisa DeCastro, Pr Nicolas Demaurex, and Pr Stephanie Hugues for the organisation and invite!

Join us for the ISREC-SCCL Symposium in Lausanne next week, cutting edge research will be presented covering the following topics: hallmarks of cancer, with a focus on tumor immunology and mechanism-guided therapies. Fondation ISREC EPFL Université de Lausanne Université de Genève isrec-symposium2023.epfl.ch

Such a great way of wrapping up a great and intense scientific day at #ISRECC2023!!! EPFL

Thrilled to share our preprint describing PTPRZ1 targeting CARTs for adult GBM. Congratulations to Dr Darel Martinez Bedoya who spearheaded this work, that we will hopefully soon translate in the clinic among other target specific CART products. Université de Genève HUG Fondation ISREC

Amazing Ludwig Distinguished Lecture given today by Prof. Hideho Okada spanning from basic neuroscience all the way to glioma antigen discovery and immune cell engineering. It was an honor to host him in Lausanne! Ludwig Cancer Okada Lab @ UCSF Parker Institute for Cancer Immunotherapy Université de Genève

Our newest #GBM CART paper now available Nature Cancer. No efficacy signal, but learned a lot about TME thanks to great work of @C_Alanio and others Institut Curie, Parker Institute for Cancer Immunotherapy, Penn Medicine, Penn Medicine - Abramson Cancer Center, Denis Migliorini, E. John Wherry, Beatty Lab nature.com/articles/s4301…

Very proud of our Penn Medicine - Abramson Cancer Center team and collaborators with this study! We are learning more with each patient to apply in our current dual targeting #CART trial and future trials. Here it is clear we can begin to remodel the #glioblastoma TME with #CART treatment #GBM Penn Neurosurgery

Prof Frank Winkler gave an outstanding Ludwig Lecture on Cancer Neuroscience, Pacemaker-like cells are fascinating! It was an honor to co-host him with Doug Hanahan.@uniheidelberg @dkfzheidelberg Fondation ISREC

Attend the #SITC IO Drug Development Summit! This program will explore modern #IO #drug development, study design, regulatory pathways & emerging #technologies. Session VI: Chimeric #Antigen Receptors with Moderator: Pedro Romero, MD - Novigenix. Register: lnkd.in/gexYHh5e

Join us at SITC Immuno-oncology Drug Development Summit in Boston! will be honored to be presenting at the CARs session about neurological safety Society for Immunotherapy of Cancer HUG UNIGE_en

Very excited to share our new paper Cancer Immunology Research. Congratulations to Darel Martinez Bedoya who led this study validating a novel CART approach to target #glioblastoma👏👏 Proud of my team and Darel with whom I am working since our time Penn Medicine Big thanks to Fondation ISREC for its support